Investor Relations

• IR Home
• Investor News & Events
• Financial Information
• Stock Information
• Corporate Governance
• Shareholder Services

IR Home

Corporate Profile

Founded in 2004, Conformis is a medical technology company focused on advancing orthopedic patient care and creating a world without joint pain. Its product portfolio is designed to maximize surgeon and patient choice by offering fully personalized solutions through its Image-to-Implant® Platinum Services℠ Program as well as data-informed, standardized solutions that combine many benefits of personalization with the convenience and flexibility of an off-the-shelf system... more >

Stock Quote

Stock Quote

(Common Stock) Change :   Volume : Data as of

IR Home

more >

Recent News

9/5/23

restor3d Completes Acquisition of Conformis

Combination Creates the World’s Preeminent Producer of Personalized Orthopedic Medical Devices, with Unmatched Additive Manufacturing Capabilities DURHAM, North Carolina and BILLERICA, Mass. , Sept. 05, 2023 (GLOBE NEWSWIRE) -- restor3d, Inc. and Conformis, Inc.

8/23/23

Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Conformis Stockholders Vote “FOR” the Pending Merger with restor3d

BILLERICA, Mass. , Aug. 23, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS ), a leading medical technology company featuring personalized knee and hip replacement products, announced today that leading independent proxy advisory firms, Institutional Shareholder Services Inc.

more >

Upcoming Events

More events are coming soon.

IR Contact

Investor Relations Phone: (781) 374-5598 E-mail: ir@conformis.com

Featured Reports

Investor Presentation 2.2 MB

Data Provided by Refinitiv. Minimum 15 minutes delayed.